Global Radiotherapy Devices Market Opportunities, Key Growth Factors, Ongoing Trends, Market Perspective and Forecast till 2022
Through technological advancements, radiotherapy devices have become more effective in oncological treatment & diagnosis ofl cancers. Medical professionals and cancer patients, both, are promoting the adoption of radiotherapy devices pertaining to their advantage in lowering hospital stay of patients and controlling the growth of cancerous tumors. This report offers a comprehensive overview on the growth of the global radiotherapy devices market till date, delivering key insights on how the market will expand during the forecast period, 2017-2022.
The scope of Fact.MR’s report is to analyze the global radiotherapy devices market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global radiotherapy devices market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to radiotherapy devices.
Request Free Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=77
Key Projections on the Global Radiotherapy Devices Market:
In 2017, global sales of linear accelerator devices is expected to procure nearly half of global radiotherapy devices market value. The sales of linear accelerators for radiotherapy is expected to gain steadfast traction, procuring an annual growth of more than US$ 280 Mn from 2017 to 2022.With soaring incidence of cancers across European countries, the healthcare infrastructure in this region is expected to remain lucrative for adoption of effective cancer therapies such as radiotherapy. The demand for radiotherapy devices is expected to gain traction in Europe owing to its advantage over other cancer therapeutic devices in terms of controlling the growth of the malignant tumors. Moreover, cancer patients are likely to remain more inclined towards radiotherapy devices that limit the hospital stay duration. According to the report, Europe will remain the largest market for radiotherapy devices throughout the forecast period.In North America, changing lifestyles of consumers and penetration of urban cultures is fuelling the incidence of pancreatic cancer. Radiotherapy devices are expected to remain of great use in treatment of pancreatic cancer and borderline resectable cancer. The radiotherapy devices market in North America is expected to witness robust gains throughout the forecast period.Manufacturers of radiotherapy devices are expected to view the Asia-Pacific excluding Japan (APEJ) region as lucrative for setting up production units. Favorable industrial regulations, low wages and high resource availability is expected to drive the growth of radiotherapy devices market in the APEJ region. The report predicts that the APEJ radiotherapy devices market is expected to grow at the fastest pace, reflecting a stellar CAGR of 11.5% through 2022.Towards the end of 2022, hospitals will emerge to be the largest end-users of radiotherapy devices. The demand for radiotherapy devices in oncological treatment centers is also anticipated to gain traction, procuring over one-fourth share on global market values throughout the forecast period.
Browse Full Report with TOC- https://www.factmr.com/report/77/radiotherapy-devices-market
High Demand for Linear Accelerator Devices
With continued advancements in medical technology, linear accelerator devices have emerged to become top-selling products in the global market for radiotherapy devices. Viewed as the most-advanced radiotherapy devices, linear accelerators produce radiation and deliver it precisely in critical procedures such as intensity modulated radiation therapy and intraoperative radiation therapy. In 2017, more than US$ 2 Bn worth of linear accelerators are expected to be sold in the global radiotherapy device market.
Oncological Treatment Centers to Boost the use of Radiotherapy Devices
Increasing preference to radiotherapy for oncological treatment of cancers is expected to influence the end-use of radiotherapy devices in specialty centers. The report predicts that hospitals will remain the largest end-users of radiotherapy devices, and also projects a soaring rise in the end-use of radiotherapy devices across oncological treatment centers in the world. Against the background of high medical costs, adoption of radiotherapy devices becomes cost-effective for oncological treatment centers. In addition this, the demand for radiotherapy devices in oncological treatment of cancers is also expected to incur influence from advantage of radiotherapy in controlling the growth of carcinogenic cells & tissues. By the end of 2022, more than US$ 1.9 Bn worth of radiotherapy devices will be sold in the global market across oncological treatment centers.
Competition Tracking
Varian Medical Systems, Elekta AB, Accuray, Inc., C.R. Bard, Inc., IBA Ion Beam Applications SA, Koninklijke Philips N.V., Siemens AG, Eckert & Ziegler Bebig, IsoRay, Inc., GE Healthcare, Vision RT Ltd., RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, AngioDynamics, Inc., Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, and Neusoft Medical Systems Co., Ltd. are key companies that are expected to remain active in the expansion of global radiotherapy devices market through 2022.
Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=77
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.